Brief: Bluebird Bio Announces Completion Of Its Restatement And Filing Of Its 2023 Form 10-K And Q1 2024 Form 10-Q
13/09/2024 23:02
bluebird bio Inc BLUE.O :
* BLUEBIRD BIO ANNOUNCES COMPLETION OF ITS RESTATEMENT AND
FILING
OF ITS 2023 FORM 10-K AND Q1 2024 FORM 10-Q
* BLUEBIRD BIO INC -RESTATEMENT HAD NO IMPACT ON COMPANY'S
CASH
POSITION OR REVENUE
Source text for Eikon: ID:nBw8wt7TFa
Further company coverage: BLUE.O
Recent news on bluebird bio
See all newsBrief: Bluebird Bio Announces Completion Of Acquisition By Carlyle And SK Capital
Brief: Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
Brief: Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment